These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 28842631)

  • 1. Elucidation of Dietary Polyphenolics as Potential Inhibitor of Microtubule Affinity Regulating Kinase 4: In silico and In vitro Studies.
    Khan P; Rahman S; Queen A; Manzoor S; Naz F; Hasan GM; Luqman S; Kim J; Islam A; Ahmad F; Hassan MI
    Sci Rep; 2017 Aug; 7(1):9470. PubMed ID: 28842631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing New Kinase Inhibitor Derivatives as Therapeutics Against Common Complex Diseases: Structural Basis of Microtubule Affinity-Regulating Kinase 4 (MARK4) Inhibition.
    Naz F; Shahbaaz M; Bisetty K; Islam A; Ahmad F; Hassan MI
    OMICS; 2015 Nov; 19(11):700-11. PubMed ID: 26565604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of human microtubule affinity-regulating kinase 4 inhibitors: fluorescence binding studies, enzyme, and cell assays.
    Naz F; Sami N; Naqvi AT; Islam A; Ahmad F; Imtaiyaz Hassan M
    J Biomol Struct Dyn; 2017 Nov; 35(14):3194-3203. PubMed ID: 27748164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and evaluation of bioactive natural products as potential inhibitors of human microtubule affinity-regulating kinase 4 (MARK4).
    Mohammad T; Khan FI; Lobb KA; Islam A; Ahmad F; Hassan MI
    J Biomol Struct Dyn; 2019 Apr; 37(7):1813-1829. PubMed ID: 29683402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, molecular docking and inhibition studies of novel 3-N-aryl substituted-2-heteroarylchromones targeting microtubule affinity regulating kinase 4 inhibitors.
    Parveen I; Khan P; Ali S; Hassan MI; Ahmed N
    Eur J Med Chem; 2018 Nov; 159():166-177. PubMed ID: 30290280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PKR-inhibitor binds efficiently with human microtubule affinity-regulating kinase 4.
    Naz F; Shahbaaz M; Khan S; Bisetty K; Islam A; Ahmad F; Hassan MI
    J Mol Graph Model; 2015 Nov; 62():245-252. PubMed ID: 26519933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based investigation of MARK4 inhibitory potential of Naringenin for therapeutic management of cancer and neurodegenerative diseases.
    Anwar S; Khan S; Shamsi A; Anjum F; Shafie A; Islam A; Ahmad F; Hassan MI
    J Cell Biochem; 2021 Oct; 122(10):1445-1459. PubMed ID: 34121218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of molecular mechanism of recognition between citral and MARK4: A newer therapeutic approach to attenuate cancer cell progression.
    Naz F; Khan FI; Mohammad T; Khan P; Manzoor S; Hasan GM; Lobb KA; Luqman S; Islam A; Ahmad F; Hassan MI
    Int J Biol Macromol; 2018 Feb; 107(Pt B):2580-2589. PubMed ID: 29079437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosmarinic Acid Exhibits Anticancer Effects via MARK4 Inhibition.
    Anwar S; Shamsi A; Shahbaaz M; Queen A; Khan P; Hasan GM; Islam A; Alajmi MF; Hussain A; Ahmad F; Hassan MI
    Sci Rep; 2020 Jun; 10(1):10300. PubMed ID: 32587267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the Inhibition of Microtubule Affinity Regulating Kinase 4 by N-Substituted Acridones.
    Voura M; Khan P; Thysiadis S; Katsamakas S; Queen A; Hasan GM; Ali S; Sarli V; Hassan MI
    Sci Rep; 2019 Feb; 9(1):1676. PubMed ID: 30737440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and biochemical investigation of MARK4 inhibitory potential of cholic acid: Towards therapeutic implications in neurodegenerative diseases.
    Anwar S; Shamsi A; Kar RK; Queen A; Islam A; Ahmad F; Hassan MI
    Int J Biol Macromol; 2020 Oct; 161():596-604. PubMed ID: 32535203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of α-Mangostin as a Potential Inhibitor of Microtubule Affinity Regulating Kinase 4.
    Khan P; Queen A; Mohammad T; Smita ; Khan NS; Hafeez ZB; Hassan MI; Ali S
    J Nat Prod; 2019 Aug; 82(8):2252-2261. PubMed ID: 31343173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of microtubule affinity regulating kinase 4 by an acetylcholinesterase inhibitor, Huperzine A: Computational and experimental approaches.
    Alrouji M; DasGupta D; Ashraf GM; Bilgrami AL; Alhumaydhi FA; Al Abdulmonem W; Shahwan M; Alsayari A; Atiya A; Shamsi A
    Int J Biol Macromol; 2023 Apr; 235():123831. PubMed ID: 36870649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structural analysis of MARK4 and the exploration of specific inhibitors for the MARK family: a computational approach to obstruct the role of MARK4 in prostate cancer progression.
    Jenardhanan P; Mannu J; Mathur PP
    Mol Biosyst; 2014 Jul; 10(7):1845-68. PubMed ID: 24763618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MARK4 Inhibited by AChE Inhibitors, Donepezil and Rivastigmine Tartrate: Insights into Alzheimer's Disease Therapy.
    Shamsi A; Anwar S; Mohammad T; Alajmi MF; Hussain A; Rehman MT; Hasan GM; Islam A; Hassan MI
    Biomolecules; 2020 May; 10(5):. PubMed ID: 32443670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human microtubule affinity-regulating kinase 4 is stable at extremes of pH.
    Naz F; Singh P; Islam A; Ahmad F; Imtaiyaz Hassan M
    J Biomol Struct Dyn; 2016 Jun; 34(6):1241-51. PubMed ID: 26208600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAP/Microtubule Affinity Regulating Kinase 4 Inhibitory Potential of Irisin: A New Therapeutic Strategy to Combat Cancer and Alzheimer's Disease.
    Waseem R; Anwar S; Khan S; Shamsi A; Hassan MI; Anjum F; Shafie A; Islam A; Yadav DK
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vanillin-Isatin Hybrid-Induced MARK4 Inhibition As a Promising Therapeutic Strategy against Hepatocellular Carcinoma.
    Ahmed S; Queen A; Irfan I; Siddiqui MN; Abdulhameed Almuqdadi HT; Setia N; Ansari J; Hussain A; Hassan MI; Abid M
    ACS Omega; 2024 Jun; 9(24):25945-25959. PubMed ID: 38911744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting inhibition of microtubule affinity regulating kinase 4 by Harmaline: Strategy to combat Alzheimer's disease.
    Adnan M; Anwar S; DasGupta D; Patel M; Elasbali AM; Alhassan HH; Shafie A; Siddiqui AJ; Bardakci F; Snoussi M; Hassan MI
    Int J Biol Macromol; 2023 Jan; 224():188-195. PubMed ID: 36257368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of pyrazolopyrimidine derivatives as microtubule affinity regulating kinase 4 inhibitors: Towards therapeutic management of Alzheimer's disease.
    Naqvi AAT; Jairajpuri DS; Noman OMA; Hussain A; Islam A; Ahmad F; Alajmi MF; Hassan MI
    J Biomol Struct Dyn; 2020 Aug; 38(13):3892-3907. PubMed ID: 31512980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.